Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tomohiro Ohgi"'
Autor:
T. Maeta, Y. Mori, M. Ono, Tomohiro Ohgi, Kazutaka Kurokohchi, Shigeki Kuriyama, T. Yachida, F. Kohi, M. Yoshida, A. Yoshitake
Publikováno v:
Endoscopy. 39
Autor:
Tomohiro Ohgi, Ichiro Matsumoto, Takaaki Kiuchi, Kazutaka Kurokohchi, Shigeki Kuriyama, Naoki Hosomi, Masahiro Ono, Tsutomu Masaki, Hirohito Yoneyama, Tsuyoshi Maeta, Akira Yoshitake, Fumikazu Kohi
Publikováno v:
Oncology reports. 16(5)
We report a case of large-size hepatocellular carcinoma (HCC) successfully treated with transarterial chemoembolization (TACE) followed by the combination therapy of percutaneous ethanol-lipiodol injection and radiofrequency ablation (PELI-RFA) and p
Autor:
Takaaki Kiuchi, Kazutaka Kurokohchi, Hirohito Yoneyama, Kazuo Ebara, Tomohiro Ohgi, Tsutomu Masaki, Akira Yoshitake, Tsuyoshi Maeta, Shunichi Hirai, Yoshitaka Kasai, Fumikazu Kohi, Masahiro Ono, Yasuhiro Kitamura, Shigeki Kuriyama
Publikováno v:
International journal of oncology. 29(2)
We previously reported that the combination therapy of percutaneous ethanol injection and radiofrequency ablation (PEI-RFA) was more effective than RFA alone in inducing wider coagulated necrosis for the treatment of hepatocellular carcinoma (HCC). I
Autor:
Kazutaka Kurokohchi, Takeshi Kako, Seiji Nakai, Tomohiro Ohgi, Yoshihiro Mori, Tsuyoshi Maeta, Hirohito Yoneyama, Fumikazu Kohi, Takaaki Kiuchi, Akira Yoshitake, Naoko Ohmachi, Tsutomu Masaki, Shigeki Kuriyama, Seishiro Watanabe, Akihiro Deguchi, Asahiro Morishita, Mitsuo Yoshida, Masahiro Ono
Publikováno v:
International Journal of Oncology.
We have previously reported that the combination therapy of percutaneous ethanol injection and radiofrequency ablation (PEI-RFA) was more effective than RFA alone to induce wider coagulated necrosis for the treatment of hepatocellular carcinoma (HCC)
Autor:
Kazutaka Kurokohchi, Hirohito Yoneyama, Akiihiro Deguchi, Tomohiro Ohgi, Asahiro Morishita, Mikio Nishioka, Yoshihiro Mori, Seiji Nakai, Masahiro Ono, Shigeki Kuriyama, Tsuyoshi Maeta, Fumikazu Kohi, Tsutomu Masaki, Keiji Arima, Akira Yoshitake
Publikováno v:
Journal of clinical immunology. 26(4)
Because the underlying mechanism of hepatocellular damages in autoimmune hepatitis (AIH) still remains unclear, analysis of CD28 and bcl-2 molecules, which are critical for T cell activation and survival, was performed in patients with AIH. The numbe
Autor:
Shigeki Kuriyama, Kazutaka Kurokohchi, Tomohiro Ohgi, Yoshiaki Miyauchi, S. Yukimasa, Seiji Nakai, Toshiharu Funaki, M. Nagai, Asahiro Morishita, Seishiro Watanabe, Tsutomu Masaki
Publikováno v:
Scandinavian journal of gastroenterology. 37(12)
Inhibitor of growth-1 (ING1) is a new candidate for the tumour suppressor gene that encodes a 33k Da protein (p33(ING1)). While reduction of p33(ING1) is an important event in some human cancers, the expression of p33(ING1) in human hepatocellular ca
Autor:
Seiji Nakai, Tsutomu Masaki, Kazutaka Kurokohchi, Asahiro Morishita, Tomohiro Ohgi, Seishiro Watanabe, Shigeki Kuriyama, Yasushi Shiratori
Publikováno v:
International Journal of Oncology.
Cyclins, cyclin-dependent kinases (CDK), and CDK inhibitors (CKI) are frequently altered in neoplasm. p57 KIP2 is a member of the KIP (kinase inhibitory protein) family of CKI and is a potential tumor suppressor gene. p27 KIP1 is the most extensively